Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gp91phox-p22phox membrane flavocytochrome complex, commonly known as Cytochrome b558, is the catalytic core of the phagocyte NADPH oxidase (NOX2) system. It is a heterodimeric integral membrane protein consisting of a large glycosylated subunit (gp91phox or NOX2) and a smaller subunit (p22phox or CYBA). Upon activation, this complex recruits cytosolic regulatory proteins to transfer electrons from NADPH to molecular oxygen, generating superoxide anions as part of the respiratory burst essential for microbial killing (UniProt P04839, P13498). Mutations in either subunit lead to Chronic Granulomatous Disease (CGD), characterized by severe recurrent infections and granuloma formation due to the inability of phagocytes to produce reactive oxygen species (PubMed: 25222463). In addition to its role in host defense, overactivation of the complex is implicated in oxidative stress-related pathologies such as atherosclerosis, hypertension, and neurodegeneration (PubMed: 29038200). Therapeutic strategies targeting this complex aim to modulate ROS production, though selectivity remains a challenge to avoid compromising the innate immune response.
Inhibition of electron transfer from NADPH to molecular oxygen, preventing the formation of superoxide radicals; disruption of the assembly of cytosolic subunits (p47phox, p67phox, p40phox) with the membrane-bound cytochrome b558 complex.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b558 (gp91phox-p22phox complex) (Cyt b558).